MediMix aims to bring high value medical information to Belgian healthcare professionals via multiple channels. Our team covers congresses and symposia all over the world, particularly in the hematology domain. In collaboration with Belgian and international experts, we bring the newest data to Belgian physicians.
In his poster presented at ASH 2024, Dr Robbe Heestermans, clinical biologist in training at the University Hospital Brussels (Brussel, Belgium), shares the results of his research into peripheral blood-based
During ASH 2024, Prof Dr Marina Konopleva from the Albert Einstein College of Medicine (Bronx, NY, USA) presented the results of a sub analysis of a phase II study evaluating
Prof Dr Cédric Hermans, a haematologist at Cliniques Universitaires Saint-Luc in Brussels presented data on emicizumab, a new treatment for haemophilia A.
In this video, Dr Claudio Cerchione, Haematologist at the Istituto Romagnolo per lo Studio dei Tumori in Meldola, Italy shares his key take aways from ASH 2024 related to the
In this video, Dr Elias Mai, haematologist at the Heidelberg University Hospital in Germany and one of the lead investigator of GMMG-HD7, shares the key take-aways of these abstracts.
In this video, Prof Jorge Cortes, haematologist at the Georgia Cancer Centre in Augusta, Georgia (USA), discusses the 5-year follow up data of this trial presented at ASH 2024.
During ASH 2024, Dr Guru Subramanian Guru Murthy from the Medical College of Wisconsin in Milwaukee chaired an oral abstract session discussing innovations in the treatment of Philadelphia chromosome-positive acute
In this video, Prof Robin Foà, emeritus professor of haematology at the Sapienza University of Rome discusses two abstracts presented at ASH zooming in on the use of ponatinib plus
